Common Anti-Malaria Drug Ordered to Carry a Black Box Warning Label
The U.S. Food and Drug Administration will now require Lariam (mefloquine hydrochloride) to carry a black box warning label due to concerns of neurological and psychiatric side effects.
Black box warning labels are reserved for the drugs with the most severe side effects.
About Lariam (Melfoquine Hydrochloride)
- Melfoquine was developed by the U.S. Military.
- The drug entered the market commercially in 1989.
- Roche’s brand name Lariam is no longer on the market, but generic versions are still available.
- Melfoquine hydrochloride is the 3rd most prescribed anti-malaria drug in the U.S. with 119,000 prescriptions between January and June of this year.
- It has been argued that the drug played a part in Robert Bales’s violent rampage in Afghanistan.
Side Effects of Lariam
For complete list click here.
- Ringing in the ears
- Unusual thoughts and behavior
- Extreme fear
- Loss of balance
Some side effects may be permanent. The drug is not to be prescribed to people who have suffered head or brain trauma.
Contact an Experienced Product Liability Attorney
Thomas J. Henry are leaders in the area of drug and product liability litigation. Our Defective Drug and Products Division have extensive knowledge and resources in order to represent our clients efficiently and aggressively. The Defective Drug and Products Division represent a multitude of people who are battling against manufacturers of medical devices and/ or defective pharmaceuticals.
If you or a loved one have been injured by or have developed serious side-effects from the use of defective medications or medical devices, contact Thomas J. Henry immediately. We represent clients/victims all over the country. We are available 24/7, nights and weekends.